D. E. Shaw & Co. Inc. Decreases Position in Fate Therapeutics, Inc. (NASDAQ:FATE)
D. E. Shaw & Co. Inc. lessened its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 54.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,536,633 shares of the biopharmaceutical company’s stock after selling 1,841,017 shares […]
D. E. Shaw & Co. Inc. lessened its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 54.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,536,633 shares of the biopharmaceutical company’s stock after selling 1,841,017 shares […]
-inc-logo-1200x675.PNG?v=20210312142656&w=240&h=240&zc=2){kind=logo}